Areas of research

Coegin Pharma's project pipeline is based on solid research and collaborations with pioneering and internationally recognized researchers and academics. Coegin Pharma was originally founded in Norway and is based on decades of research. With the recent acquisition of Follicum, Coegin Pharma has added new and promising peptide-based drug candidates that have been shown to protect human cells from metabolic stress associated with diabetes, which has the potential to reduce organ damage in diabetic patients.

Actinic keratosis is sun damage to the skin caused by excessive sun exposure during the course of life. It is a very common precursor to skin cancer.

Basal cell carcinoma is the most common form of skin cancer and the most common of all cancers.

Leukemia is a general term that includes acute and chronic lymphoblastic leukemia (ALL, CLL) and acute and chronic myeloid leukemia (AML, CML).

Liver and kidney fibrosis

Cardiovascular complications Diabetes is associated with a 2- to 3-fold increased risk of cardiovascular disease (CVD) including acute myocardial infarction and stroke, independent of the type of diabetes. Most acute cardiovascular events are caused by the rupture of an atherosclerotic plaque, which can be fatal. Complications of diabetes, such as CVD, kidney failure, blindness and diabetic foot ulcers, are profound and costly to the society with rising health care costs.

Wound healing

Stimulation of hair growt